#cell cycle regulation

Cell Cycle Regulation

The APC/C-Cdh1 complex is required for:

Specificity and timing of APC/C activity arise from sequential association with two adaptors, Cdc20 and Cdh1, both containing seven WD40 repeats forming beta-propeller that binds D-box and KEN motifs. During prometaphase and metaphase, APC/C-Cdc20 polyubiquitinates securin and cyclin B to trigger anaphase and mitotic exit. At telophase, cyclin B degradation reduces CDK1 activity, allowing Cdc14 phosphatase to dephosphorylate Cdh1, enabling its binding to APC/C core. APC/C-Cdh1 then operates from late mitosis through entire G1, continuously ubiquitinating mitotic cyclins A and B, mitotic kinases Polo and Aurora, Geminin inhibitor of licensing, and even Cdc20 itself, ensuring low CDK environment. Low CDK permits pre-replication complex formation consisting of ORC, Cdc6, Cdt1, and double hexamer of MCM2-7 helicase loaded at origins. As cyclin E-CDK2 accumulates at G1/S, it phosphorylates Cdh1 creating 14-3-3 sites, displacing it from APC/C and inactivating ligase, allowing S-phase cyclin accumulation and transition to next cycle. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Peters, Nature Reviews Mol Cell Biol 2006, APC/C Mechanisms. Alberts 7th ed., Chapter 17.

View Details

Cell Cycle Regulation

In yeast, which protein is the functional equivalent of Rb in regulating the G1/S transition?

In mammalian cells, Rb represses E2F until cyclin D-CDK4/6 phosphorylates pocket domain, but budding yeast Saccharomyces cerevisiae lacks Rb ortholog and uses functionally analogous repressor Whi5 to regulate Start checkpoint analogous to Restriction Point. Whi5 contains CDK phosphorylation sites and binds heterodimeric transcription factor SBF composed of Swi4 DNA-binding protein recognizing SCB elements and Swi6 coactivator. In early G1 when CDK activity low, unphosphorylated Whi5 resides in nucleus, physically interacting with SBF at promoters of CLN1, CLN2, CLB5, and many cell wall synthesis genes, recruiting histone deacetylases Hos3 and Rpd3 to block transcription. As cell grows, Cln3 cyclin synthesized proportionally to size binds Cdc28 CDK1 and phosphorylates Whi5, triggering export via Msn5 karyopherin. SBF liberated induces Cln1 and Cln2 that further phosphorylate Whi5 in positive feedback loop analogous to cyclin E-CDK2 hyperphosphorylating Rb. Nuclear exit defines commitment to replication and budding, illustrating convergent regulatory logic. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Cross et al., Annu Rev Cell Dev Biol 2007, Yeast G1/S Control. NCBI Bookshelf: Whi5 Rb Analog.

View Details

Cell Cycle Regulation

The key regulatory checkpoint for DNA replication completion before mitosis is:

Before mitosis, cells must verify complete and accurate genome duplication to avoid mitotic breakage of under-replicated chromosomes. G2/M checkpoint operates as surveillance system mediated by ATR-Chk1 and ATM-Chk2 kinases activated by RPA-coated single-stranded DNA at stalled forks and double-strand breaks respectively. Chief effectors are Cdc25 phosphatase family isoforms B and C that normally remove inhibitory Thr14 and Tyr15 phosphorylations placed on CDK1 by Wee1 and Myt1 nuclear kinases, triggering abrupt CDK1 activation. Checkpoint kinases phosphorylate Cdc25B/C at Ser216 and Ser323 generating 14-3-3 protein docking sites, leading to cytoplasmic sequestration away from nuclear cyclin B-CDK1 pool, keeping CDK1 inhibited. p53 pathway adds parallel inhibition via p21 induction and Gadd45 binding to PCNA-CDK1 complex. When replication finishes and lesions repaired, phosphatases PP2A and PP1 reverse checkpoint phosphorylations, allowing nuclear import of Cdc25 and autocatalytic amplification loop that drives lamin phosphorylation, chromosome condensation, and centrosome separation. Surveillance prevents premature segregation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Lodish et al., Molecular Cell Biology, 9th ed., Chapter 20: G2/M Checkpoint and Replication Completion.

View Details

Cell Cycle Regulation

What happens if the Rb protein is mutated and cannot be phosphorylated?

Retinoblastoma protein Rb functions as central gatekeeper integrating mitogenic signaling with E2F transcription program controlling G1/S restriction point. In quiescent or early G1 cells, Rb exists in hypophosphorylated state, binding E2F1, E2F2, E2F3 through pocket domains A and B, simultaneously recruiting histone deacetylases, SWI/SNF chromatin remodelers, and Polycomb complexes to repress promoters of cyclin E, cyclin A, thymidine kinase, dihydrofolate reductase, and DNA polymerase subunits. Mitogens induce cyclin D-CDK4/6 synthesis downstream of Ras-MAPK and PI3K pathways, which initiates progressive phosphorylation of Rb at serine 780, 795, 807, 811. Subsequent cyclin E-CDK2 mediated hyperphosphorylation fully displaces Rb, liberating E2F to activate S-phase genes. Mutation eliminating CDK phosphorylation sites locks Rb in constantly bound conformation, maintaining E2F repression despite abundant cyclin-CDK activity. Consequently, cells fail to transcribe nucleotide biosynthesis enzymes and replication factors, arresting before S-phase commitment, illustrating how non-phosphorylatable Rb creates dominant negative barrier to proliferation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Weinberg, Biology of Cancer, 2nd ed., Chapter 8: Rb Pathway. NCBI Bookshelf: Cell Cycle Control.

View Details

Cell Cycle Regulation

Which enzyme removes inhibitory phosphate from CDK1 to activate mitosis?

Release from Wee1-mediated inhibition is pivotal for mitotic entry, executed by Cdc25 family of dual specificity phosphatases capable of hydrolyzing phospho-threonine, phospho-serine and phospho-tyrosine. Three isoforms A, B, C exist in mammals, each with N-terminal regulatory domain containing 14-3-3 binding sites, nuclear export signals, Polo box binding motifs, and C-terminal catalytic domain bearing HCX5R active site with catalytic cysteine. During unperturbed cycle Cdc25B initiates activation at centrosomes early G2, followed by Cdc25C amplifying response. Polo-like kinase 1 phosphorylates Cdc25C at Ser214 enhancing activity, while CDK1 itself phosphorylates N-terminus creating positive feedback leading to abrupt switch. Checkpoint kinases Chk1 and Chk2 phosphorylate Ser216 promoting 14-3-3 sigma binding and cytoplasmic retention to maintain inhibitory phosphorylations on CDK1-Cyclin B. Active Cdc25 dephosphorylates CDK1 Tyr15 and Thr14 within activation segment exposing ATP-binding residues for catalysis increasing MPF activity more than hundredfold within minutes. In fission yeast cdc25 mutants delay mitosis increasing cell length, overexpression shortens size confirming role as dose-dependent mitotic inducer opposing Wee1 length regulatory pathway. Additional feedback loops involving polo-like kinases, phosphatases and SCF-mediated degradation reinforce irreversibility and protect against premature progression that would compromise genome integrity and viability.

Ref: Nilsson & Hoffmann, Cdc25 Phosphatases Activate CDK1 for Mitosis, Cell Cycle 2000; Alberts et al., Chapter 17, Cdc25 Function.

View Details

Cell Cycle Regulation

Which Cyclin-CDK complex is responsible for the G1/S transition?

Transition from growth phase G1 into DNA synthesis S phase requires activation of gene expression program and licensing factor conversion. In early G1, Cyclin D-CDK4/6 partially phosphorylates Rb after mitogen stimulation allowing limited E2F activity producing Cyclin E. Cyclin E accumulation reaches zenith in late G1 forming active kinase with CDK2. Cyclin E-CDK2 completes hyperphosphorylation of Rb at distinct sites including Ser612 Ser807, fully dissociating Rb from E2F1-E2F3 activators. Liberated E2F-DP heterodimers bind promoters with TTTCCCGC motifs driving transcription of replication genes such as Cyclin A, dihydrofolate reductase, thymidylate synthase, PCNA, Cdc6, CDT1, MCM helicase subunits and DNA polymerase alpha delta epsilon. Simultaneously Cyclin E-CDK2 phosphorylates Kip1 inhibitor p27 at Thr187 creating phosphodegron for SCF-Skp2-Cks1 ubiquitination and degradation, eliminating CDK2 inhibition. It also phosphorylates Treslin TICRR and RecQL4 facilitating Cdc45-MCM-GINS helicase activation for origin firing. Expression transient because SCF-Fbw7 targets autophosphorylated Cyclin E for destruction, restricting activity window. Amplification frequently observed in ovarian and breast cancers driving replication stress and genomic instability. Additional feedback loops involving polo-like kinases, phosphatases and SCF-mediated degradation reinforce irreversibility and protect against premature progression that would compromise genome integrity and viability.

Ref: Hinds, Cyclin E-CDK2 Complex and G1/S Transition Control, Cell Cycle 2002; Alberts et al., Chapter 17, G1/S Regulator.

View Details

Cell Cycle Regulation

Which protein is the catalytic subunit in cell cycle regulation?

Cell cycle progression driven by oscillating cyclin-dependent kinase activities where temporal regulation derived from cyclin synthesis and degradation while catalytic function resides within CDK subunit. Cyclins contain cyclin box fold binding hydrophobic patch on CDK but lack enzymatic residues for phosphate transfer. CDKs share bilobal kinase architecture with ATP binding pocket between N and C lobes, PSTAIRE helix aligning catalytic residues and activation T-loop blocking substrate binding when unphosphorylated. Cyclin binding rotates PSTAIRE helix inward positioning Glu51 to coordinate Lys33 for ATP orientation and moves T-loop aside exposing substrate binding groove. Full activation additionally requires phosphorylation at conserved threonine 160 in CDK2 or 161 in CDK1 by CAK complex CDK7-Cyclin H-MAT1 stabilizing T-loop interaction with substrate peptide through arginine pocket, and removal of inhibitory phosphorylations at Thr14 Tyr15 added by Wee1 Myt1 kinases via Cdc25 phosphatases. Active CDK then transfers gamma phosphate of ATP to serine-threonine-proline motifs on hundreds of targets, powering cell cycle transitions. Hence catalytic subunit capable of phosphotransfer is CDK, cyclins provide allosteric activation, localization and substrate specificity.

Ref: Morgan, Cyclin-Dependent Kinases Structure and Activation, Annu Rev Cell Dev Biol 1997; Alberts et al., Chapter 17, CDK as Catalytic Subunit.

View Details

Cell Cycle Regulation

What is the function of the Mitotic Exit Network (MEN)?

Mitotic Exit Network enables yeast cells to coordinate chromosome segregation completion with cytokinesis induction, preventing division before genome partitioned. The network is G-protein coupled kinase cascade anchored at spindle pole bodies. GTPase Tem1, kept inactive when spindle misaligned by Kin4-mediated phosphorylation of Bfa1-Bub2 GAP complex, becomes activated as daughter spindle pole body enters bud containing activating factor Lte1, a guanine nucleotide exchange factor like protein that antagonizes Bub2-Bfa1 hydrolysis activity. GTP-bound Tem1 recruits and activates Cdc15 kinase via scaffold Nud1, Cdc15 then phosphorylates and activates Dbf2-Mob1 LATS-like kinase complex. Dbf2-Mob1 phosphorylates Cfi1/Net1 inhibitor of Cdc14 as well as Cdc14 itself on nuclear localization signals, promoting dissociation from nucleolus and export to cytoplasm. Free Cdc14 dephosphorylates Cdh1 activating APC/C-Cdh1 for mitotic cyclin destruction, Swi5 enabling Sic1 transcription blocking CDK1, and other cytokinesis regulators. Result extinguishes CDK1 activity driving spindle disassembly, actin ring contraction and septum synthesis, finalizing division with appropriate genome segregation. Additional feedback loops involving polo-like kinases, phosphatases and SCF-mediated degradation reinforce irreversibility and protect against premature progression that would compromise genome integrity and viability.

Ref: Bardin & Amon, The Mitotic Exit Network Signaling Cascade, Nat Rev Mol Cell Biol 2001; NCBI, Yeast MEN Pathway Components.

View Details

Cell Cycle Regulation

APC/C-Cdh1 is required for:

After separase cleavage of cohesin and chromosome segregation, cells must eliminate remaining mitotic cyclins to establish low CDK environment permissive for origin licensing, transcription reactivation and cytokinesis in G1. Two sequential APC/C coactivators accomplish temporal ordering. APC/C-Cdc20 initiates anaphase by destroying securin and majority of cyclin B during metaphase to anaphase transition. Cdc20 itself then becomes substrate for APC/C-Cdh1. Cdh1, also known as Fzr1, associates with APC/C core from late anaphase through G1, recognizing extended degron repertoire including KEN-box, D-box and ABBA motifs. Targets include residual cyclin B, cyclin A, Plk1, Aurora kinases A and B, Cdc20, geminin, Skp2 and Ets transcription factors. Continued degradation prevents re-accumulation of CDK1-Cyclin B activity, maintaining stable G1 state that allows formation of pre-replicative complexes containing ORC, Cdc6, Cdt1 and MCM helicases. At G1/S border, Cdh1 phosphorylated by CDK2-Cyclin E and inhibited by Emi1 pseudosubstrate, allowing cyclin buildup for next S phase. Loss of Cdh1 causes persistent mitotic kinases, premature S entry and genomic instability. Additional feedback loops involving polo-like kinases, phosphatases and SCF-mediated degradation reinforce irreversibility and protect against premature progression that would compromise genome integrity and viability.

Ref: Lindon, APC/C-Cdh1 Control of G1 Homeostasis, Biochem J 2008; Peters, Anaphase Promoting Complex Mechanism and Regulation.

View Details

Cell Cycle Regulation

What is the function of p31 comet in checkpoint silencing?

The spindle assembly checkpoint generates the Mitotic Checkpoint Complex containing closed Mad2, BubR1, Bub3 and Cdc20, which potently inhibits APC/C until all kinetochores attach. Checkpoint silencing requires active disassembly of this inhibitor once alignment completes. p31comet, also called MAD2L1BP and Trip13 adaptor, functions as dedicated MCC antagonist. Structurally mimicking Mad2, p31comet selectively binds the closed conformation of Mad2, termed C-Mad2, occupying the same interface that normally contacts BubR1 and therefore competitively extracting BubR1 from MCC. Together with AAA+ ATPase TRIP13, p31comet catalyzes the energetic conversion of C-Mad2 back to open O-Mad2, a conformer incapable of sequestering Cdc20. The resulting p31comet-C-Mad2-Cdc20 intermediate is recognized by TRIP13 which hydrolyzes ATP to unfold Mad2 safety belt. Released Cdc20 then activates APC/C for securin and cyclin B ubiquitination. p31comet also caps the Mad1-Mad2 core at kinetochores, preventing de novo generation of closed Mad2, ensuring rapid, switch-like APC/C activation and anaphase onset while preventing prolonged metaphase arrest and chromosome missegregation risks associated with persistent checkpoint signaling in mitosis. Additional feedback loops involving polo-like kinases, phosphatases and SCF-mediated degradation reinforce irreversibility and protect against premature progression that would compromise genome integrity and viability.

Ref: Alfieri et al., TRIP13-p31comet mechanism in MCC disassembly, Nature Communications 2018; Musacchio, SAC silencing, Curr Biol.

View Details

Cell Cycle Regulation

What is the role of p53 in the G1 checkpoint?

G1 progression toward S phase is driven by cyclin-dependent kinases CDK4/6-cyclin D and CDK2-cyclin E that phosphorylate retinoblastoma protein Rb, releasing transcription factor E2F to induce genes for DNA replication enzymes, nucleotide biosynthesis, and replication licensing factors such as Cdc6. DNA damage in G1 would risk copying lesions, necessitating arrest. Tumor suppressor p53 serves as guardian by acting as transcription factor stabilized upon ATM-CHK2 signaling after double-strand breaks. One of its principal targets is CDKN1A encoding p21CIP1/WAF1, a potent inhibitor of CDK2-cyclin E and CDK2-cyclin A complexes. p21 binds and inhibits kinase active site, preventing phosphorylation of Rb and downstream substrates like Cdc6 and keeping E2F repressed, thereby imposing G1 arrest and allowing time for repair. p53 also induces GADD45 and 14-3-3 sigma contributing to pause. p53 does not degrade Rb, directly phosphorylate Cdc25, or ubiquitinate securin; those actions belong to other regulators. Through p21 induction, p53 enforces G1 checkpoint, and loss of this axis contributes to unchecked proliferation and genomic instability in majority of human cancers.

Ref: El-Deiry et al., Cell 1993, p21 as p53 Target; Bertoli et al., Nature Rev Mol Cell Biol 2013, G1-S Regulation.

View Details

Cancer

Tumor suppressor genes primarily function to

Suppress uncontrolled cell proliferation, is consistent with established principles of cell signaling, receptor pharmacology and cellular regulation. Experimental measurements of binding parameters, genetic loss-of-function studies and pharmacological interventions all converge on the same interpretation. Related options address neighboring concepts but do not satisfy the precise criterion stated in the question.

Ref: NCERT Biology Class 11–12 Alberts et al Molecular Biology of the Cell Lodish et al, Molecular Cell Biology Cooper & Hausman, The Cell Abbas et al., Cellular and Molecular Immunology (for immunology sections)

View Details